Dr. Kari B. Wisinski
Claim this profileUniversity of Wisconsin Carbone Cancer Center
Expert in Breast Cancer
Studies Cancer
20 reported clinical trials
51 drugs studied
Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 positive
Stage IV
2Cancer
HER2 positive
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Kari B. Wisinski is currently running
18F-FFNP PET/MRI
for Breast Cancer
This clinical trial will investigate an estrogen-regulated parameter as an early measure of endocrine therapy response: progesterone receptor (PR) protein with a progestin-based radioligand, 18F-fluorofuranylnorprogesterone (18F-FFNP). The overall purpose of this research is to test the efficacy of 18F-FFNP PET/MRI for predicting response to presurgical endocrine therapy and to determine the quantitative reliability of 18F-FFNP breast PET/MRI in patients with newly diagnosed PR+ primary breast cancer.
Recruiting1 award Phase 27 criteria
Alpelisib + Tucatinib
for Breast Cancer
This trial tests a combination of two drugs, tucatinib and alpelisib, in patients with a specific type of advanced breast cancer. These patients have a genetic mutation and a type of cancer that may not respond well to standard treatments. The drugs work by blocking signals that help cancer cells grow. Alpelisib is approved for treating certain types of advanced breast cancer.
Recruiting1 award Phase 1 & 211 criteria
More about Kari B. Wisinski
Clinical Trial Related7 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Kari B. Wisinski has experience with
- Pembrolizumab
- Fulvestrant
- Trastuzumab
- Ribociclib
- Anastrozole
- Letrozole
Breakdown of trials Kari B. Wisinski has run
Breast Cancer
Cancer
Breast cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kari B. Wisinski specialize in?
Kari B. Wisinski focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved ER positive patients, or patients who are HER2 positive.
Is Kari B. Wisinski currently recruiting for clinical trials?
Yes, Kari B. Wisinski is currently recruiting for 11 clinical trials in Madison Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Kari B. Wisinski has studied deeply?
Yes, Kari B. Wisinski has studied treatments such as Pembrolizumab, Fulvestrant, Trastuzumab.
What is the best way to schedule an appointment with Kari B. Wisinski?
Apply for one of the trials that Kari B. Wisinski is conducting.
What is the office address of Kari B. Wisinski?
The office of Kari B. Wisinski is located at: University of Wisconsin Carbone Cancer Center, Madison, Wisconsin 53792 United States. This is the address for their practice at the University of Wisconsin Carbone Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.